Abstract
Tissue type plasminogen activator (tPA) plays a role in differentiation of neurones and activity-dependent structural changes in neurones. We hypothesised that tPA would also be present in CSF during fibrinolysis after intraventricular haemorrhage. We measured tPA antigen in CSF from 13 normal newborn infants and 14 infants with posthaemorrhagic ventricular dilation (PHVD). tPA was undetectable or at the limit of detection (1 μg/l) in normal CSF. The CSF tPA concentration ranged from 1.3 to 3.5 μg/l in the infants with PHVD. Serial tapping in one infant showed persistence of tPA in the CSF from 3 to 8 weeks of age. We conclude that endogenous tPA may be part of the physiological response to intraventricular haemorrhage or may be present as a result of passive diffusion into the CSF.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IVH :
-
intraventricular haemorrhage
- LTP :
-
long-term potentiation
- PHVD :
-
post-haemorrhagic ventricular dilatation
- tPA :
-
tissue plasminogen activator
References
Brinker T, Seifert V, Dietz H (1992) Subacute hydrocephalus after experimental subarachnoid hemorrhage: its prevention by intrathecal fibrinolysis with recombinant tissue plasminogen activator. Neurosurgery 31:306–312
Corrigan JJ, Jeter MA (1992) Tissue-type plasminogen activator, plasminogen activator inhibitor and histidinerich glycoproteins in stressed human newborns. Pediatrics 89:43–46
De Vries LS, Larroche JC, Levene MI (1988) Germinal matrix haemorrhage and intraventricular haemorrhage. In: Levene MI, Bennett M, Punt J (eds) Fetal and rleonatal neurology and neurosurgery. Churchill Livingstone, Edinburgh pp 312–325
Findlay JM, Weir B, Kassell NF, Disney LB, Grace MG (1991) Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75:181–188
Findlay JM, Weir BKA, Stollery DE (1991) Lysis of intraventricular hematoma with tissue plasminogen activator. J Neurosurg 74:803–807
Hill A, Shackleford GD, Volpe JJ (1984) A potential mechanism of pathogenesis for early post-hemorrhagic hydrocephalus in the premature newborn. Pediatrics 73:19–21
Larroche JC (1972) Posthaemorrhagic hydrocephalus in infancy. Biologia Neonatorum 20:287–299
Levene MI (1981) Measurement of the growth of the lateral ventricles in preterm infants with real time ultrasound. Arch Dis Child 56:900–904
Mizoi, K., Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T (1993) Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78:430–437
Neuman T, Stephens RW, Salonen EM, Tinmusk T, Vaheri A (1989) Induction of morphological differentialtion of human neuroblastoma cells is accompanied by induction of tissue type plasminogen activator. J Neurosci Res 23:274–281
Öhman J, Servo A, Heiskanen O (1991) Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarchnoid hemorrhage. J Neurosurg 75:197–201
Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular clot with urokinase in a canine model. 3. Effects of intraventricular urokinase on clot lysis and posthaemorrhagic hydrocephalus. Neurosurgery 19:553–572
Pittman RN, Ivins JK, Buettner HM (1989) Neuronal plasminogen activator: cell surface binding sites and involvement in neurite outgrowth. J Neurosci 9:4269–4286
Qian Z, Gilbert ME, Colicos MA, Kandel E, Kuhl D (1993) Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361:453–457
Stolke D, Seifert V (1992) Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarchnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 30:877–881
Ventriculomegaly Trial Group (1990) Randomised trial of early tapping v conservative management in infants with post-haemorrhagic hydrocephalus. Arch Dis Child 65:3–10
Whitelaw A (1993) Endogenous fibrinolysis in neonatal cerebrospinal fluid. Eur J Pediatr 152:928–930
Whitelaw A, Creighton L, Gaffney P (1991) Fibrinolytic activity in CSF after intraventricular haemorrhage. Arch Dis Child 66:808–809
Zabramski JM, Spetzler RF, Lee S, Papodopoulos S, Bovill E, Zimmerman RS, Bederson J (1991) Phase 1 trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:189–196
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Whitelaw, A., Mowinckel, MC., Fellman, V. et al. Endogenous tissue plasminogen activator in neonatal cerebrospinal fluid. Eur J Pediatr 155, 117–119 (1996). https://doi.org/10.1007/BF02075763
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02075763